Sign in

    Jarwei Fang

    Vice President and Analyst at Citi

    Jarwei Fang is a Vice President and Analyst at Citi, focusing on financial services and investment analysis. While specific companies covered and detailed performance metrics are not publicly available, his position at Citi involves high-level analytical responsibilities within the firm’s banking operations. Fang's career trajectory includes serving as Vice President at Citi, with earlier experience and credentials not clearly indicated in publicly accessible sources. Professional licensing and industry recognitions for Jarwei Fang are not specified in available data.

    Jarwei Fang's questions to Amylyx Pharmaceuticals (AMLX) leadership

    Jarwei Fang's questions to Amylyx Pharmaceuticals (AMLX) leadership • Q2 2025

    Question

    Jarwei Fang, on behalf of Jeff Meacham, asked about overcoming the lack of an ICD-10 code to demonstrate the PBH market need to payers and about the level of patient community awareness for the PSP and Wolfram syndrome trials.

    Answer

    Co-CEO & Co-Founder Josh Cohen noted that work on an ICD-10 code is active and that claims analysis supports their market estimates. He highlighted the significant unmet need conveyed by physicians. Chief Medical Officer Dr. Camille Bedrosian added that the PSP patient community is very supportive, and Cohen mentioned growing awareness and referrals for Wolfram syndrome.

    Ask Fintool Equity Research AI